Endogenous Metabolites and Genome Instability in Aging and Disease
Chemical Research in Toxicology · 2023
DOI: 10.1021/acs.chemrestox.3c00288 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Chemical Research in Toxicology, 2023. Verfasst von Rachana Tomar und 1 weiteren Autor:innen. Beteiligte Einrichtung: Department of Chemistry, Vanderbilt University, Nashville, Tennessee 37235, United States. Hauptthemen laut MEDLINE: Aging, Genomic Instability. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 10 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NCI NIH HHS, NIEHS NIH HHS, NIGMS NIH HHS.
Abstract (Originalsprache)
Proper maintenance of genomic DNA is upheld by tight control of cellular metabolism and DNA processing. Herein, we review recent advances in examining the role of endogenous metabolites and genomic instability in aging and disease as presented at the Fall 2023 American Chemical Society Meeting.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Chemistry, Vanderbilt University, Nashville, Tennessee 37235, United States.
- Department of Medicinal Chemistry, University of Kansas, Lawrence, Kansas 66044, United States.
ORCID-Profile: Luke Erber
Förderung
- NCI NIH HHS
- NIEHS NIH HHS
- NIGMS NIH HHS
- National Institute of Environmental Health Sciences
- National Cancer Institute
- National Institute of General Medical Sciences
Zitieren
APA
Tomar, R., & Erber, L. (2023). Endogenous Metabolites and Genome Instability in Aging and Disease. Chemical Research in Toxicology. https://doi.org/10.1021/acs.chemrestox.3c00288
Vancouver
Tomar R, Erber L. Endogenous Metabolites and Genome Instability in Aging and Disease. Chemical Research in Toxicology. 2023. doi:10.1021/acs.chemrestox.3c00288
BibTeX
@article{Tomar2023,
author = {Tomar, Rachana and Erber, Luke},
title = {Endogenous Metabolites and Genome Instability in Aging and Disease},
journal = {Chemical Research in Toxicology},
year = {2023},
doi = {10.1021/acs.chemrestox.3c00288}
}
EUVIMED